Skip to content

Improving Sleep and Learning in Rehabilitation After Stroke, Part 2

Improving Sleep and Learning in Rehabilitation After Stroke, Part 2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05511285
Acronym
INSPIRES-2
Enrollment
100
Registered
2022-08-22
Start date
2022-09-13
Completion date
2027-12-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Sleep, Rehabilitation, Digital, Cognitive Behavioural Therapy for Insomnia, Motor consolidation

Brief summary

This study will explore whether sleep in stroke survivors is improved with digital cognitive behavioural therapy for insomnia (Sleepio), in comparison to treatment as usual, and will explore whether changes in sleep relate to changes in overnight consolidation of motor learning.

Detailed description

Stroke is one of the leading causes of adult disability. Rehabilitation of movement after stroke depends on motor learning. Motor learning involves not only improvement during practice but also offline improvement, or consolidation, that occurs after practice. Consolidation of learning depends on good sleep quality. However, sleep is disrupted long-term after stroke and patients with poorer sleep show worse rehabilitation outcomes. Cognitive behavioural therapy for insomnia (CBT) is the recommended first line treatment for sleep problems. "Sleepio" is a digital CBT programme which is effective across a range of clinical populations. This study aims to test the efficacy of digital CBT for reducing insomnia symptoms after stroke, in comparison with usual care alone. To explore the possibility that sleep interventions might enhance rehabilitation outcomes via their impact on consolidation of motor learning, the study will additionally test for differences in consolidation between groups, and explore whether changes in sleep measures are associated with changes in consolidation. Participants will be randomised to either receive digital CBT for insomnia (in addition to usual care) or receive treatment as usual alone (2:1 treatment to control ratio). The primary outcome is the score on the 8-item Sleep Condition Indicator, 10 weeks following randomisation. Secondary outcomes include behavioural measures of overnight motor consolidation assessed as the change in motor task performance from training to retest, sleep disruption assessed with actigraphy, and depression and fatigue using the Patient Health Questionnaire (PHQ9) and the Fatigue Severity Scale respectively. In addition to this, to explore the feasibility of delivering rehabilitation following the sleep improvement programme, an optional 4 weeks of upper limb motor training at home will be offered to all participants (regardless of group allocation) after follow-up. Outcomes of adherence to the training and upper limb function will be assessed.

Interventions

6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online, in addition to usual care.

Sponsors

University of Oxford
Lead SponsorOTHER
Big Health Inc.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Randomisation and facilitation of the intervention will be performed by a research assistant, and the person analysing the data will be blinded to group allocations.

Intervention model description

A randomised controlled trial with two parallel study arms: (1) digital cognitive behavioural therapy for insomnia (experimental condition), and (2) treatment as usual (control condition). Randomisation will be using a 2:1 ratio (experimental:control), within minimisation of between group differences in age, sex, baseline Sleep Condition Indicator score and time since stroke.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Willing and able to give informed consent for participation in the study * Aged 18 years or above. * Clinical diagnosis of stroke affecting the upper limb, with sufficient movement to perform the motor learning task * Discharged from inpatient care * Interest in accessing a programme with the aim of improving sleep quality * Reliable access to the internet

Exclusion criteria

* Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis) * Diagnosed, untreated, sleep disorder (e.g. Sleep Apnea) * Uncontrolled seizures * Planned inpatient admission (e.g. for rehabilitation) in the next 4 months that would impact ability to engage with the Sleepio programme * Engagement in psychological therapy for insomnia in the past 12 months * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Sleep Condition Indicator10 weeks after randomisationQuestionnaire assessing self-reported insomnia symptoms, range 0-32, higher numbers indicate less symptoms of insomnia

Secondary

MeasureTime frameDescription
Change in motor performance from training to retest10 weeks after randomisationBehavioural motor consolidation assessment, assessed as accuracy (range 0-50, higher numbers indicate better accuracy of motor performance)
Patient Health Questionnaire10 weeks after randomisationQuestionnaire assessing symptoms of depression, range 0-20, higher values indicate more depressive symptoms
Fatigue Severity Scale10 weeks after randomisationQuestionnaire assessing fatigue, range 9-63, higher score indicates more severe fatigue
Actigraphy10 weeks after randomisationWearable activity monitor used for assessing sleep disruption (Total Sleep Time, Wake After Sleep Onset, sleep fragmentation)

Countries

United Kingdom

Contacts

CONTACTMelanie K Fleming, Dr
melanie.fleming@ndcn.ox.ac.uk01865 611 461
CONTACTBarbara Robinson
sleep-win@ndcn.ox.ac.uk
PRINCIPAL_INVESTIGATORMelanie K Fleming, Dr

University of Oxford

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026